Skip to Main ContentSkip to FooterSkip to Search
Main menu
  1. Home
  2.  » 
  3. Expert Content
  4.  » 
  5. Inhalation
  6.  » Intranasal Drug Product Development – From Formulation to Scaleup Manufacturing
Icon of a document with a pencil

Intranasal Drug Product Development -From Formulation to Scaleup Manufacturing

Summary: The intranasal delivery route is frequently used to treat both acute and chronic indications. In this Q&A article, Catalent experts Jan Neelissen, Kiran Amancha and David Wilcox discuss intranasal drug product development, in particular best practices and key considerations, from formulation design to manufacture and scale-up.

View the Q&A Article